期刊
CELLULAR SIGNALLING
卷 27, 期 7, 页码 1517-1524出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2015.03.004
关键词
Experimental autoimmune myocarditis; Chronic heart failure; Cardiac remodeling; CHST15 siRNA
类别
资金
- Yujin Memorial Grant, Ministry of Education, Culture, Sports, Science, and Technology, Japan [23602012]
- promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]
- Japan Science and Technology Agency (JST), Japan [AS2117901G]
- Grants-in-Aid for Scientific Research [23602012, 24590938] Funding Source: KAKEN
Carbohydrate sulfotransferase 15 (CHST15) is a sulfotransferase responsible for biosynthesis of chondroitin sulfate E (CS-E), which plays important roles in numerous biological events such as biosynthesis of proinflammatory cytokines. However, the effects of CHST15 siRNA in rats with chronic heart failure (CHF) after experimental autoimmune myocarditis (EAM) have not yet been investigated. CHF was elicited in Lewis rats by immunization with cardiac myosin, and after immunization, the rats were divided into two groups and treated with either CHST15 siRNA (2 mu g/week) or vehicle. Age matched normal rats without immunizations were also included in this study. After 7 weeks of treatment, we investigated the effects of CHST15 siRNA on cardiac function, proinflammatory cytokines, and cardiac remodeling in RAM rats. Myocardial functional parameters measured by hemodynamic and echocardiographic studies were significantly improved by CHST15 siRNA treatment in rats with CHF compared with that of vehicle-treated CHF rats. CHST15 siRNA significantly reduced cardiac fibrosis, and hypertrophy and its marker molecules (left ventricular (LV) mRNA expressions of transforming growth factor betal, collagens land III, and atrial natriuretic peptide) compared with vehicle-treated CHF rats. CHF-induced increased myocardial mRNA expressions of proinflammatory cytokines [interleukin (IL)-6, IL-1 beta], monocyte chemoattractant protein-1, and matrix metalloproteinases (MMP-2 and -9), and CHST15 were also suppressed by the treatment with CHST15 siRNA. Western blotting study has confirmed the results obtained from mRNA analysis as CHST5 siRNA treated rats expressed reduced levels of inflammatory and cardiac remodeling marker proteins. Our results demonstrate for the first time, that CHST15 siRNA treatment significantly improved LV function and ameliorated the progression of cardiac remodeling in rats with CHF after EAM. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据